Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
British Journal of Cancer
|
January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
Michael D Hogarty, David S Ziegler, Andrea Franson, et al.
Neuro-Oncology
|
February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
JACC. Cardiooncology
|
July 3, 2023
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
Purnima Singh, David K Crossman, Liting Zhou, et al.
Scientific Reports
|
August 4, 2023
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy
Purnima Singh, Liting Zhou, Disheet A Shah, et al.
Pediatric Blood & Cancer
|
May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies
David S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Cancer
|
June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Journal of the American Heart Association
|
September 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report
Purnima Singh, Disheet A Shah, Mariam Jouni, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
British Journal of Cancer
|
January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
Michael D Hogarty, David S Ziegler, Andrea Franson, et al.
Neuro-Oncology
|
February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
JACC. Cardiooncology
|
July 3, 2023
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
Purnima Singh, David K Crossman, Liting Zhou, et al.
Scientific Reports
|
August 4, 2023
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy
Purnima Singh, Liting Zhou, Disheet A Shah, et al.
Pediatric Blood & Cancer
|
May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies
David S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Cancer
|
June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Journal of the American Heart Association
|
September 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report
Purnima Singh, Disheet A Shah, Mariam Jouni, et al.
Page
of 10